GoodRx Holdings (GDRX) Other Non-Current Assets (2019 - 2026)

GoodRx Holdings has reported Other Non-Current Assets for 8 years, with the latest figure at $29.6 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 29.56% year-over-year to $29.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.6 million (up 29.56% YoY) and the FY2025 annual result came in at $29.1 million, up 23.7% from the prior year.
• Other Non-Current Assets advanced to $29.6 million in Q1 2026 per GDRX's latest filing, from $29.1 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $44.5 million in Q2 2023 and troughed at $20.9 million in Q1 2022.
• A 5-year average of $31.5 million and a median of $29.6 million in 2026 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 1603.9% in 2022, then plunged 37.92% in 2025.
• Over 5 years, Other Non-Current Assets stood at $27.2 million in 2022, then jumped by 39.06% to $37.8 million in 2023, then tumbled by 37.74% to $23.5 million in 2024, then climbed by 23.7% to $29.1 million in 2025, then grew by 1.61% to $29.6 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $29.6 million, $29.1 million, and $23.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.